Search Within

Mrinal M Gounder

  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (119)
  2. Journal Article (98)
  3. Review (4)
  4. Guidelines (2)
  5. Research Letter (2)
  6. Book Section (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (229)
  2. Sarcoma Service (229)
  3. Solid Tumor Oncology Division (229)
  4. GSK Faculty (87)
  5. Hematologic Malignancies, Division of (85)
  6. Tow Center for Developmental Oncology (TCDO) (83)

More Groups

People
  1. William Tap (78)
  2. Mary Keohan (73)
  3. Sandra D'Angelo (73)
  4. Mark Dickson (70)
  5. Ping Chi (57)
  6. Li-Xuan Qin (52)

More People

Years
  1. 2025 (6)
  2. 2024 (17)
  3. 2023 (21)
  4. 2022 (36)
  5. 2021 (16)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (86)
  2. Annals of Oncology (24)
  3. Clinical Cancer Research (20)
  4. Cancer (7)
  5. The Oncologist (6)
  6. European Journal of Cancer (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (88)
  2. Oxford University Press (30)
  3. American Association for Cancer Research (29)
  4. Springer (14)
  5. Elsevier Inc. (11)
  6. Nature Publishing Group (10)

More Publishers

Results (229)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of the MDM2 inhibitor milademetan in patients with TP53-wild type and MDM2-amplified advanced or metastatic solid tumors (MANTRA-2)
    Meeting Abstract

    Dumbrava, E. E.; Hanna, G. J.; Cote, G. M.; Stinchcombe, T.; Johnson, M. L.; Chen, C.; Devarakonda, S.; Shah, N.; Xu, F.; Doebele, R. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Results of a phase I dose escalation and expansion study of tegavivint (BC2059), a first-in-class TBL1 inhibitor for patients with progressive, unresectable desmoid tumor
    Meeting Abstract

    Cranmer, L. D.; Razak, A. R. A.; Ratan, R.; Choy, E.; George, S.; Liebner, D. A.; Stenehjem, D. D.; Gounder, M. M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Growth factor signaling and kinase inhibitors regulate oncogenesis in desmoid fibromatosis by modulating activity of the beta-catenin transcription target ABL1
    Meeting Abstract

    Hu, J.; Villano, A.; O'Connor, R.; Rozenberg, Y.; Venkatesh, A.; Gounder, M.; Socci, N.; Singer, S.; Hameed, M.; Crago, A. M.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Selinexor in advanced, metastatic dedifferentiated liposarcoma: A multinational, randomized, double-blind, placebo-controlled trial
    Journal Article

    Gounder, M. M.; Razak, A. A.; Somaiah, N.; Chawla, S.; Martin-Broto, J.; Grignani, G.; Schuetze, S. M.; Vincenzi, B.; Wagner, A. J.; Chmielowski, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
    Guidelines

    Stacchiotti, S.; Maria Frezza, A.; Demetri, G. D.; Blay, J. Y.; Bajpai, J.; Baldi, G. G.; Baldini, E. H.; Benjamin, R. S.; Bonvalot, S.; BoveĢe, J. V. M. G.; more...
    Cancer Treatment Reviews (2022)

    Fulltext@MSK | Save
  • Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
    Journal Article

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S. A.; Antonescu, C. R.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N. D.; Rana, S.; Zehir, A.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
    Journal Article

    D'Angelo, S. P.; Richards, A. L.; Conley, A. P.; Woo, H. J.; Dickson, M. A.; Gounder, M.; Kelly, C.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
    Journal Article

    Gounder, M. M.; Agaram, N. P.; Trabucco, S. E.; Robinson, V.; Ferraro, R. A.; Millis, S. Z.; Krishnan, A.; Lee, J.; Attia, S.; Abida, W.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Transarterial chemoembolization with doxorubicin eluting beads for extra-abdominal desmoid tumors: Initial experience
    Journal Article

    Kim, D.; Keohan, M. L.; Gounder, M. M.; Crago, A. M.; Erinjeri, J. P.
    CardioVascular and Interventional Radiology (2022)

    Fulltext@MSK | Save
  • Facial subcutaneous dermatofibrosarcoma protuberans treated with imatinib and monitored with magnetic resonance: A therapeutic alternative for unresectable cases
    Research Letter

    Navarrete-Dechent, C.; Shah, K.; Mori, S.; Gounder, M. M.; Stambuk, H. E.; Nehal, K. S.
    Dermatologic Therapy (2022)

    Fulltext@MSK | Save